JP2020508297A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020508297A5 JP2020508297A5 JP2019543913A JP2019543913A JP2020508297A5 JP 2020508297 A5 JP2020508297 A5 JP 2020508297A5 JP 2019543913 A JP2019543913 A JP 2019543913A JP 2019543913 A JP2019543913 A JP 2019543913A JP 2020508297 A5 JP2020508297 A5 JP 2020508297A5
- Authority
- JP
- Japan
- Prior art keywords
- fever
- compound
- formula
- infection
- take
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims description 9
- -1 1-amino - tetratriacontyl Chemical group 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims 5
- 239000012453 solvate Substances 0.000 claims 5
- 206010024229 Leprosy Diseases 0.000 claims 4
- 206010035148 Plague Diseases 0.000 claims 4
- 208000037386 Typhoid Diseases 0.000 claims 4
- 241000607479 Yersinia pestis Species 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 4
- 201000008297 typhoid fever Diseases 0.000 claims 4
- 208000035143 Bacterial infection Diseases 0.000 claims 3
- 206010024238 Leptospirosis Diseases 0.000 claims 3
- 208000022362 bacterial infectious disease Diseases 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 208000004429 Bacillary Dysentery Diseases 0.000 claims 2
- 241000193738 Bacillus anthracis Species 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 2
- 206010006500 Brucellosis Diseases 0.000 claims 2
- 206010069748 Burkholderia pseudomallei infection Diseases 0.000 claims 2
- 206010051226 Campylobacter infection Diseases 0.000 claims 2
- 208000007190 Chlamydia Infections Diseases 0.000 claims 2
- 206010008631 Cholera Diseases 0.000 claims 2
- 206010018612 Gonorrhoea Diseases 0.000 claims 2
- 241000589248 Legionella Species 0.000 claims 2
- 208000007764 Legionnaires' Disease Diseases 0.000 claims 2
- 206010024641 Listeriosis Diseases 0.000 claims 2
- 208000016604 Lyme disease Diseases 0.000 claims 2
- 206010027202 Meningitis bacterial Diseases 0.000 claims 2
- 208000037942 Methicillin-resistant Staphylococcus aureus infection Diseases 0.000 claims 2
- 206010029443 Nocardia Infections Diseases 0.000 claims 2
- 206010029444 Nocardiosis Diseases 0.000 claims 2
- 201000005702 Pertussis Diseases 0.000 claims 2
- 206010035664 Pneumonia Diseases 0.000 claims 2
- 241000287531 Psittacidae Species 0.000 claims 2
- 206010037660 Pyrexia Diseases 0.000 claims 2
- 241000283984 Rodentia Species 0.000 claims 2
- 241000607142 Salmonella Species 0.000 claims 2
- 206010039587 Scarlet Fever Diseases 0.000 claims 2
- 206010040550 Shigella infections Diseases 0.000 claims 2
- 206010043376 Tetanus Diseases 0.000 claims 2
- 208000034784 Tularaemia Diseases 0.000 claims 2
- 201000009904 bacterial meningitis Diseases 0.000 claims 2
- 206010013023 diphtheria Diseases 0.000 claims 2
- 208000028104 epidemic louse-borne typhus Diseases 0.000 claims 2
- 210000004907 gland Anatomy 0.000 claims 2
- 208000001786 gonorrhea Diseases 0.000 claims 2
- 201000001371 inclusion conjunctivitis Diseases 0.000 claims 2
- 201000004015 melioidosis Diseases 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 208000007865 relapsing fever Diseases 0.000 claims 2
- 201000005113 shigellosis Diseases 0.000 claims 2
- 208000006379 syphilis Diseases 0.000 claims 2
- 206010044325 trachoma Diseases 0.000 claims 2
- 201000008827 tuberculosis Diseases 0.000 claims 2
- 206010061393 typhus Diseases 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021095156A JP7101293B2 (ja) | 2017-02-21 | 2021-06-07 | 新規ポリイミノケトアルデヒド |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/HR2017/000002 WO2018154344A1 (en) | 2017-02-21 | 2017-02-21 | New polyimino ketoaldehydes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021095156A Division JP7101293B2 (ja) | 2017-02-21 | 2021-06-07 | 新規ポリイミノケトアルデヒド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020508297A JP2020508297A (ja) | 2020-03-19 |
| JP2020508297A5 true JP2020508297A5 (https=) | 2020-04-30 |
Family
ID=58530574
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019543913A Pending JP2020508297A (ja) | 2017-02-21 | 2017-02-21 | 新規ポリイミノケトアルデヒド |
| JP2021095156A Active JP7101293B2 (ja) | 2017-02-21 | 2021-06-07 | 新規ポリイミノケトアルデヒド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021095156A Active JP7101293B2 (ja) | 2017-02-21 | 2021-06-07 | 新規ポリイミノケトアルデヒド |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US11180444B2 (https=) |
| EP (1) | EP3598868B1 (https=) |
| JP (2) | JP2020508297A (https=) |
| KR (1) | KR102296053B1 (https=) |
| CN (1) | CN110325245A (https=) |
| AU (1) | AU2017399805B2 (https=) |
| CA (1) | CA3053236C (https=) |
| DK (1) | DK3598868T3 (https=) |
| ES (1) | ES2888948T3 (https=) |
| HR (1) | HRP20211412T1 (https=) |
| PL (1) | PL3598868T3 (https=) |
| PT (1) | PT3598868T (https=) |
| RU (1) | RU2749376C1 (https=) |
| SI (1) | SI3598868T1 (https=) |
| WO (1) | WO2018154344A1 (https=) |
| ZA (1) | ZA201905612B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018154344A1 (en) * | 2017-02-21 | 2018-08-30 | Novum Spero Ltd. | New polyimino ketoaldehydes |
| EP3843877A4 (en) | 2018-08-27 | 2022-08-24 | Electric Power Research Institute, Inc. | ORGANIC METAL FRAMEWORKS FOR THE REMOVAL OF MULTIPLE LIQUID-PHASE COMPOUNDS AND METHODS OF USE AND PRODUCTION THEREOF |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018154344A1 (en) * | 2017-02-21 | 2018-08-30 | Novum Spero Ltd. | New polyimino ketoaldehydes |
-
2017
- 2017-02-21 WO PCT/HR2017/000002 patent/WO2018154344A1/en not_active Ceased
- 2017-02-21 CA CA3053236A patent/CA3053236C/en active Active
- 2017-02-21 AU AU2017399805A patent/AU2017399805B2/en active Active
- 2017-02-21 RU RU2019126389A patent/RU2749376C1/ru active
- 2017-02-21 CN CN201780087044.4A patent/CN110325245A/zh active Pending
- 2017-02-21 DK DK17716587.5T patent/DK3598868T3/da active
- 2017-02-21 PT PT177165875T patent/PT3598868T/pt unknown
- 2017-02-21 KR KR1020197026606A patent/KR102296053B1/ko active Active
- 2017-02-21 EP EP17716587.5A patent/EP3598868B1/en active Active
- 2017-02-21 JP JP2019543913A patent/JP2020508297A/ja active Pending
- 2017-02-21 PL PL17716587T patent/PL3598868T3/pl unknown
- 2017-02-21 ES ES17716587T patent/ES2888948T3/es active Active
- 2017-02-21 US US16/487,162 patent/US11180444B2/en active Active
- 2017-02-21 HR HRP20211412TT patent/HRP20211412T1/hr unknown
- 2017-02-21 SI SI201730887T patent/SI3598868T1/sl unknown
-
2019
- 2019-08-26 ZA ZA2019/05612A patent/ZA201905612B/en unknown
-
2021
- 2021-06-07 JP JP2021095156A patent/JP7101293B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Marshall et al. | Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid | |
| JP2017510580A5 (https=) | ||
| JP2013542992A5 (https=) | ||
| JP2012512262A5 (https=) | ||
| Mat Rahim et al. | Facing the challenges of multidrug-resistant Acinetobacter baumannii: progress and prospects in the vaccine development | |
| JP2018525423A5 (https=) | ||
| JP2020508297A5 (https=) | ||
| JP2020097577A5 (https=) | ||
| JP2013539751A5 (https=) | ||
| JP2012529443A5 (https=) | ||
| JP2015528468A5 (https=) | ||
| JP2021525787A5 (https=) | ||
| RU2015132569A (ru) | Полимиксины, композиции с ними, способы получения и способы применения | |
| CY1108498T1 (el) | Συνθεση εμβολιου η οποια περιεχει ως εκδοχο μια αλκυλφωσφατιδυλοχολινη | |
| Lambrecht et al. | Inability to detect mycobactin in mycobacteria-infected tissues suggests an alternative iron acquisition mechanism by mycobacteria in vivo | |
| JP7035206B2 (ja) | クロルヘキシジン塩基、生体消毒薬及び非生体消毒薬組成物の可溶化 | |
| HRP20211412T1 (hr) | Novi polimino ketoaldehidi | |
| JP2014513700A5 (https=) | ||
| JP2024009968A5 (https=) | ||
| Lepage et al. | Multiresistant Salmonella typhimurium systemic infection in Rwanda. Clinical features and treatment with cefotaxime | |
| ATE504333T1 (de) | Behandlung mykobakterieller infektionen mit cyclipostinen | |
| JP2017526767A5 (https=) | ||
| US20240261257A1 (en) | Methods of treating bacterial infections | |
| JP2005524622A5 (https=) | ||
| Rodriguez et al. | Utilization of Fe3+-acinetoferrin analogs as an iron source by Mycobacterium tuberculosis |